The creator sold all their Nvidia (NVDA) shares to reinvest in Healthcare AI stocks.
Source Post
I sold my Nvidia shares to buy the next massive wave: Healthcare AI. The trade isn’t just about drugs; it’s...
Jan 24, 2026
The creator is selling Nvidia (NVDA) to invest in three Healthcare AI stocks: Adaptive Biotechnologies (ADPT), Prime Medicine (PRME), and Guardant Health (GH). The reel outlines the specific reasons for investing in each company, focusing on their innovative technologies in disease detection, gene editing, and cancer prevention.
Linked Mentions
Tickers discussed in this post
Guardant Health (GH) is a buy, referred to as the 'Tesla of Oncology,' due to its FDA-approved 'Shield' blood test for cancer screening, which is replacing invasive methods.
Prime Medicine (PRME) is a buy for its proprietary gene editing technology, described as a 'word processor' for DNA, offering Nobel Prize-worthy innovation at a low price.
Adaptive Biotechnologies (ADPT) is a buy due to its 'Google Maps' of the immune system and its MRD test, which is becoming the standard for disease detection.